The clinical significance of LINK-A in tumors has drawn considerable attention (Lin et al., 2016; Lin et al., 2017; Filippov-Levy et al., 2018; Ma and Xue, 2018; Zhao et al., 2018; Zhang et al., 2019a; Zhang et al., 2019b; Chen et al., 2019; Hua et al., 2019; Liu et al., 2019; Zhao et al., 2019; Kong et al., 2020; Li et al., 2020; Maleki et al., 2020; Zhang et al., 2020; Ghahfarokhi et al., 2023; Nan et al., 2023), evident in its dysregulated expression profiles observed in both tumor tissues and blood samples across various malignant tumors (Table 2). The gene discussed is LINC01139; the disease is neoplasm.